Scandinavian Journal of Rheumatology

Tacrolimus for the treatment of active rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials
pp. 271-278(8)
Authors: Lee, YH; Woo, J-H; Choi, SJ; Ji, JD; Bae, S-C; Song, GG

Expression of full-length and splice forms of FoxP3 in rheumatoid arthritis
pp. 279-286(8)
Authors: Ryder, LR; Woetmann, A; Madsen, HO; Ødum, N; Ryder, LP; Bliddal, H; Danneskiold-Samsøe, B; Ribel-Madsen, S; Bartels, EM

Contribution of anti-CCP antibodies, proximal interphalangeal joint involvement, HLA-DRB1 shared epitope, and PADI4 as risk factors for the development of rheumatoid arthritis in palindromic rheumatism
pp. 287-291(5)
Authors: Tamai, M; Kawakami, A; Iwamoto, N; Arima, K; Aoyagi, K; Eguchi, K

Self-reported food intolerance and mucosal reactivity after rectal food protein challenge in patients with rheumatoid arthritis
pp. 292-298(7)
Authors: Lidén, M; Kristjánsson, G; Valtysdottir, S; Venge, P; Hällgren, R

Small joint involvement in psoriatic arthritis is associated with onycholysis: the Reykjavik Psoriatic Arthritis Study
pp. 299-302(4)
Authors: Love, TJ; Gudjonsson, JE; Valdimarsson, H; Gudbjornsson, B

Comparison of the Psoriatic Arthritis Quality of Life (PsAQoL) questionnaire, the functional status (HAQ) and utility (EQ-5D) measures in psoriatic arthritis: results from a cross-sectional survey
pp. 303-309(7)
Authors: Brodszky, V; Péntek, M; Bálint, PV; Géher, P; Hajdu, O; Hodinka, L; Horváth, G; Koó, É; Polgár, A; Seszták, M; Szántó, S; Ujfalussy, I; Gulácsi, L

Incidence and prevalence of psoriatic arthritis, ankylosing spondylitis, and reactive arthritis in the first descriptive population-based study in the Czech Republic
pp. 310-317(8)
Authors: Hanova, P; Pavelka, K; Holcatova, I; Pikhart, H

Self-rated physical and psychosocial health in a cohort of young adults with juvenile idiopathic arthritis
pp. 318-325(8)
Authors: Östile, IL; Johansson, I; Aasland, A; Flatö, B; Möller, A

Subclinical atherosclerosis in scleroderma patients
pp. 326-329(4)
Authors: Tsifetaki, N; Georgiadis, AN; Alamanos, Y; Fanis, S; Argyropoulou, MI; Drosos, AA

Impaired exercise performance in systemic sclerosis and its clinical correlations
pp. 330-335(6)
Authors: Cuomo, G; Santoriello, C; Polverino, F; Ruocco, L; Valentini, G; Polverino, M

Comparison between swallowing-related and limb muscle involvement in dermatomyositis patients
pp. 336-340(5)
Authors: Kim, SJ; Han, TR; Jeong, SJ; Beom, JW

Serum interleukin-5 levels correlate with disease activity of Churg-Strauss syndrome in a patient treated with a leucotriene receptor antagonist, pranlukast, and inhaled corticosteroid
pp. 341-343(3)
Authors: Taki, H; Shinoda, K; Hounoki, H; Ogawa, R; Ishizawa, S; Sugiyama, E; Tobe, K

Non-participation in EIRA: a population-based case-control study of rheumatoid arthritis
pp. 344-346(3)
Authors: Bengtsson, C; Berglund, A; Serra, M-L; Nise, L; Nordmark, B; Klareskog, L; Alfredsson, L; EIRA study group,

Rectal involvement revealing Wegener's disease
pp. 346-348(3)
Authors: Marie, I; Lahaxe, L; Josse, S; Lequerre, T; Vittecoq, O; Savoye, G

Successful control of scleroderma myocarditis using a combination of cyclophosphamide and methylprednisolone
pp. 349-350(2)
Authors: Stack, J; McLaughlin, P; Sinnot, C; Henry, M; MacEneaney, P; Eltahir, A; Harney, S

Pulmonary-renal syndrome in hepatitis C infection and rheumatoid arthritis
pp. 351-352(2)
Authors: Lateef, A; Dn, Yy; Thamboo, Tp; Lim, Ayn